ArticlePredictive and Prognostic Impact of Tumor-Infiltrating Lymphocytes (CD8+) In Breast Cancer Treated With Neoadjuvant Chemotherapy
ArticlePredictive and Prognostic Impact of Tumor-Infiltrating Lymphocytes (CD8+) In Breast Cancer Treated With Neoadjuvant Chemotherapy
ArticleTumor Infiltrating Lymphocytes Predicting Long-Term Outcomes in HER2-Negative Breast Cancer Patients with Visceral Metastases
ArticleTumor Infiltrating Lymphocytes Predicting Long-Term Outcomes in HER2-Negative Breast Cancer Patients with Visceral Metastases
ArticlePrognostic Value of Tumour Infiltrating T-Lymphocytes (Tils) with Special Preference to CD8 Positive T-Lymphocyte in Muscle Invasive Urothelial Bladder Cancer
ArticlePrognostic Value of Tumour Infiltrating T-Lymphocytes (Tils) with Special Preference to CD8 Positive T-Lymphocyte in Muscle Invasive Urothelial Bladder Cancer
ArticleNegative lymph nodes number and lymph node ratio as independent prognostic factors for triple-negative breast cancer outcome - Hospital based cohort study
ArticleNegative lymph nodes number and lymph node ratio as independent prognostic factors for triple-negative breast cancer outcome - Hospital based cohort study
ArticleExpression of Tumor infiltrating Lymphocytes (Tils), Forkhead Box P3 (FOXP3) and Cyclooxygenase-2 (COX2) in Breast Cancer Patient’s Tumor Tissue, A Single Institute Study
ArticleExpression of Tumor infiltrating Lymphocytes (Tils), Forkhead Box P3 (FOXP3) and Cyclooxygenase-2 (COX2) in Breast Cancer Patient’s Tumor Tissue, A Single Institute Study
ArticlePrevalence of Androgen Receptors Expression in Triple Negative Breast Cancer Patients and its Correlation with Clinicopathological Criteria: Our Institutes Experience
ArticlePrevalence of Androgen Receptors Expression in Triple Negative Breast Cancer Patients and its Correlation with Clinicopathological Criteria: Our Institutes Experience
ArticleSTUDY THE PROGNOSTIC VALUE OF INFLAMMATORY BLOOD MARKER FOR OVERALL SURVIVAL IN NON-METASTATIC BREAST CANCER
ArticleSTUDY THE PROGNOSTIC VALUE OF INFLAMMATORY BLOOD MARKER FOR OVERALL SURVIVAL IN NON-METASTATIC BREAST CANCER